Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis

International Journal of Cancer. Journal International Du Cancer
K ButzF Hoppe-Seyler

Abstract

The E6 gene of tumor-associated types of human papillomaviruses codes for a functional antagonist of p53. Overexpression of E6 from heterologous promoters can block p53-mediated cellular responses to DNA damage, such as transcriptional stimulation of p53 target genes and cell-cycle arrest in G1. In contrast, genotoxic treatment of HPV-positive cancer cells, which express the E6 gene from chromosomally integrated viral copies, results in increased expression of the p53 target gene p21WAF1 and, in several cell lines, induction of G1 arrest. In the present study, we show that treatment with genotoxic agents, such as mitomycin C and cisplatin, leads to strong repression of viral E6/E7 oncogene expression in HPV16- and HPV18-positive cervical carcinoma cell lines. Kinetic analyses revealed that reduction of E6/E7 expression was not a prerequisite for induction of p21WAF1. We furthermore found that the apoptosis-promoting bax gene could be induced by genotoxic stress in some, but not all, HPV-positive cancer cell lines. Treatment with DNA-damaging agents eventually resulted in apoptotic cell death of HPV-positive cancer cells, irrespective of their capacity to induce the p53 target gene bax. These results support the notion that HPV-...Continue Reading

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Feb 24, 1995·Cell·E M MiyashitaD A Thorley-Lawson
Sep 1, 1995·Genes & Development·Y HauptM Oren
Feb 1, 1995·Current Opinion in Genetics & Development·R Haffner, M Oren
Jan 1, 1994·Methods in Cell Biology·Z DarzynkiewiczJ Gong
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J SlebosK R Cho
Jan 1, 1994·Current Topics in Microbiology and Immunology·H zur Hausen
Jan 1, 1994·Current Topics in Microbiology and Immunology·M ScheffnerP M Howley
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T D KessisK R Cho
Jan 3, 1996·International Journal of Cancer. Journal International Du Cancer·C H NilssonM Dürst
Nov 1, 1995·Current Opinion in Oncology·S W Lowe
Nov 1, 1995·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·F Hoppe-Seyler, K Butz

❮ Previous
Next ❯

Citations

Feb 11, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P BossiL Licitra
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J A Fonseca-MoutinhoC F de Oliveira
Oct 9, 2008·Journal of Cancer Research and Clinical Oncology·Paolo Boscolo-RizzoAnnarosa Del Mistro
Apr 28, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Psyrri, E Cohen
Jun 10, 2010·The New England Journal of Medicine·Douglas R Lowy, Karl Munger
Aug 6, 2013·Otolaryngologic Clinics of North America·Juliana Bonilla-VelezJames W Rocco
Feb 14, 2013·Gynecologic Oncology·Gabriella Lillsunde LarssonMats G Karlsson
Feb 10, 2012·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·S GuihardG Noël
May 11, 2010·The Lancet Oncology·Shanthi MarurArlene A Forastiere
Jan 17, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Im Il NaYoon Sang Shim
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Wei LiBarbara R Rose
Oct 11, 2008·Journal of Cellular Biochemistry·Józefa Wesierska-GadekSusanne B Hajek
Jun 2, 2011·International Journal of Cancer. Journal International Du Cancer·Hun Soon JungYoung Kee Shin
Jul 30, 2010·The Laryngoscope·Clint T AllenBrian Nussenbaum
Sep 3, 2011·Asia-Pacific Journal of Clinical Oncology·David I PryorSandro V Porceddu
Jun 26, 2013·International Journal of Cancer. Journal International Du Cancer·Jinn-Li WangH Eugene Liu
Oct 2, 2009·International Journal of Cancer. Journal International Du Cancer·Alain C JungBohdan Wasylyk
Jun 23, 2004·Biochemical and Biophysical Research Communications·Lih-Ching HsuRaymond L White
Apr 14, 2015·Head & Neck·Samip N PatelDavid P Goldstein
Jun 2, 2014·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Martina A BroglieSandro J Stoeckli
Mar 14, 2000·Seminars in Cancer Biology·F Mantovani, L Banks
Nov 17, 2015·Hematology/oncology Clinics of North America·Sidharth V Puram, James W Rocco
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Józefa Wesierska-GadekMarcel Horky
Oct 3, 2001·International Journal of Cancer. Journal International Du Cancer·Y HarimaT Ohnishi
Mar 22, 2000·Antisense & Nucleic Acid Drug Development·M TraidejJ Chen
Aug 29, 2018·Journal of Clinical Medicine·Kazuhiro KobayashiTatsuhiko Miyazaki
Jul 13, 2006·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Katie L Green, Kevin Gaston

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.